Ocular Therapeutix (OCUL)
(Delayed Data from NSDQ)
$4.75 USD
+0.55 (12.98%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.74 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Earnings News For OCUL
-
Ocular Therapeutix (OCUL) Reports Q4 Loss, Misses Revenue Estimates
-
Ocular Therapeutix: Q4 Earnings Snapshot
-
Ocular Therapeutix? Reports Fourth Quarter and Full Year 2023 Results
-
Ocular Therapeutix (OCUL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Ocular Therapeutix: Q3 Earnings Snapshot
-
Ocular Therapeutix (OCUL) Reports Q2 Loss, Tops Revenue Estimates
-
Ocular Therapeutix: Q2 Earnings Snapshot
-
Ocular Therapeutix (OCUL) Reports Q1 Loss, Lags Revenue Estimates
-
Ocular Therapeutix: Q1 Earnings Snapshot
-
Ocular Therapeutix (OCUL) Reports Q4 Loss, Tops Revenue Estimates
-
Ocular Therapeutix: Q4 Earnings Snapshot
-
Ocular Therapeutix (OCUL) Reports Q3 Loss, Lags Revenue Estimates (Revised)
-
Ocular Therapeutix: Q3 Earnings Snapshot
-
Ocular Therapeutix? Reports Third Quarter 2022 Financial Results and Business Update
-
Ocular Therapeutix (OCUL) Reports Q2 Loss, Lags Revenue Estimates
-
Ocular Therapeutix: Q2 Earnings Snapshot
-
Ocular Therapeutix? Reports Second Quarter 2022 Financial Results and Business Update
-
Ocular Therapeutix (OCUL) Reports Q1 Loss, Lags Revenue Estimates
-
Ocular Therapeutix (OCUL) Reports Q4 Loss, Lags Revenue Estimates
-
Ocular Therapeutix (OCUL) Reports Q3 Loss, Tops Revenue Estimates
-
Earnings Preview: Ocular Therapeutix (OCUL) Q3 Earnings Expected to Decline
-
Ocular Therapeutix (OCUL) Reports Q2 Loss, Tops Revenue Estimates
-
Will Ocular Therapeutix (OCUL) Report Negative Earnings Next Week? What You Should Know
-
Ocular Therapeutix (OCUL) Reports Q4 Loss, Lags Revenue Estimates
-
Will Ocular Therapeutix (OCUL) Report Negative Earnings Next Week? What You Should Know